• About us
• Contact

Advertisement

Organisation › Details

Bioptimus SAS

Bioptimus is building the first universal foundation model in biology to drive advancements in scientific research and biotechnological innovation. By employing state-of-the-art AI technologies and accessing unique proprietary data, we aim to shape the future of scientific research and improve healthcare outcomes globally. *

 

	Start	2023-09-26 established
	Industry	AI-based drug discovery / AI-based drug development
	Industry 2	BIOTECH
	Region	Paris
	Country	France
	Street	14 boulevard Poissonniere
	City	75009 Paris
		Address record changed: 2024-02-20
Basic data	Employees	n. a.
		* Document for »About Section«: Bioptimus SAS. (2/20/24). "Press Release: Ex-Google DeepMind and Owkin Scientists Team up to Create Bioptimus to Build the First Universal AI Foundation Model for Biology".
		Record changed: 2024-03-30

Advertisement

More documents for Bioptimus SAS

• [1] Bioptimus SAS. (1/14/25). "Press Release: Bioptimus Hits $76M Funding Milestone and Prepares to Launch Groundbreaking Foundation Model for Biology"....
• [2] Bioptimus SAS. (7/11/24). "Press Release: Bioptimus Launches H-optimus-0, the World’s Largest Open-source AI Foundation Model for Pathology"....
• [3] Bioptimus SAS. (2/20/24). "Press Release: Ex-Google DeepMind and Owkin Scientists Team up to Create Bioptimus to Build the First Universal AI Foundation Model for Biology"....

To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to [email protected] and simply fill the subject line with the word »LSE Newsletter«

Find more infos about advertising at [iito] web portals in our media flyer [iito] in a Nutshell [PDF file]

Advertisement

» top

» Imprint  |  » Data Privacy  |  » Contact  |  The use of this website requires to accept the » Disclaimer!   |  A project of [iito] Business Intelligence © 2002-2025. Made in Germany.